ABSTRACT: Background: Gastric cancer and gastric precancerous lesions are highly prevalent in China. However, prevalence of the different precancerous lesions has not been reported from the north-east ...
Gaten Matarazzo, known for playing Dustin in Stranger Things, lives with cleidocranial dysplasia (CCD), a rare genetic disorder affecting bone and teeth development. He uses his platform to raise ...
Barrett’s esophagus is a condition in which the normal lining of the esophagus is replaced by a type of tissue similar to that found in the intestine. This change, known as intestinal metaplasia, ...
Geleophysic dysplasia is a rare genetic condition that causes a smaller physical stature, as well as challenges with joints and internal organs, among others. Geleophysic dysplasia (GD) is inherited ...
A phase II study of perioperative intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology. Total neoadjuvant therapy with induction ...
NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc.
Background While p53 mutations occur early in Barrett’s oesophagus (BE) progression to oesophageal adenocarcinoma (EAC), their role in gastric cardia stem cells remains unclear. Objective This study ...
Dysplasia diagnoses double with the addition of WATS-3D to forceps biopsies among patients with GERD. Wide-area transepithelial sampling (WATS-3D) plus forceps biopsy (FB) increases detection of ...
CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and surveillance of Barrett’s esophagus (BE) and dysplasia, reported positive data in a recently published study, Benefit ...
Barrett’s esophagus (BE) might recur after complete eradication of intestinal metaplasia (CEIM). We investigated factors associated with recurrence of BE after successful Radiofrequency ablation (RFA) ...
Background: Choledochal cyst (CDC) increases the risk (2.5%–30%) of malignancy. Metaplasia and dysplasia have been recognized as premalignant lesions among CDCs ...